Skip to main content
Microbot Medical Inc. logo

Microbot Medical Inc. — Investor Relations & Filings

Ticker · MBOT ISIN · US59503A2042 LEI · 549300AEUNO16KTJXD72 US Manufacturing
Open in API
Filings indexed 1,062 across all filing types
Latest filing 2020-10-13 Director's Dealing
Country US United States of America
Listing US MBOT

About Microbot Medical Inc.

http://www.microbotmedical.com/

Microbot Medical Inc. is a commercial-stage medical device company focused on transforming endovascular procedures with advanced robotic technology. The company researches, designs, and develops robotic endoluminal surgery devices for the minimally invasive surgery market. Its flagship product, the LIBERTY® Endovascular Robotic System, is the first single-use, remotely operated robotic solution designed to provide physicians with enhanced precision, control, and efficiency. Developed in collaboration with experts in Interventional Radiology, Neuroradiology, and Cardiology, the system aims to improve patient care and physician safety.

Recent filings

Filing Released Lang Actions
Director's Dealing 2020
Director's Dealing
2020-10-13 English
Regulatory Filings 2020
Regulatory Filings Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text indicates it is a short report (3831 characters) announcing a press release about a patent allowance notice from the USPTO. It includes no financial statements or detailed financial data, only a brief disclosure and a press release as an exhibit. The document explicitly states it is furnished pursuant to Item 7.01 Regulation FD Disclosure, which is typically used for material news announcements. Given the short length and nature of the content, this is not a full financial report or earnings release but a regulatory filing announcing a material event. Therefore, it fits best under Regulatory Filings (RNS).
2020-10-07 English
Director's Dealing 2020
Director's Dealing
2020-10-06 English
Director's Dealing 2020
Director's Dealing
2020-09-09 English
Director's Dealing 2020
Director's Dealing
2020-09-09 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated September 1, 2020, by Microbot Medical Inc. It reports the submission of matters to a vote of security holders at the Annual Meeting held on that date. The document details the voting results for four proposals, including election of directors, ratification of the independent auditor, advisory approval of executive compensation, and approval of a performance award plan. The content is focused on reporting the official results of shareholder votes at a general meeting. There is no detailed financial data, management discussion, or full report attached. The document is not an annual or quarterly report, nor a proxy solicitation, but specifically the voting results announcement. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 4618 characters, which is sufficient to contain substantive voting results rather than a mere announcement of a report publication.
2020-09-04 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.